Literature DB >> 24693470

Nocardia brain abscess in an immunocompetent patient.

Suyoung Kim1, Kang Lock Lee1, Dong Min Lee1, Ji Hun Jeong2, Song Mi Moon1, Yiel-Hae Seo2, Chan Jong Yoo3, Dongki Yang4, Yong Kyun Cho1, Yoon Soo Park1.   

Abstract

Nocardia cerebral abscess is rare, constituting approximately 1-2% of all cerebral abscesses. Mortality for a cerebral abscess of Nocardia is three times higher than that of other bacterial cerebral abscesses, therefore, early diagnosis and therapy is important. Nocardia cerebral abscess is generally occur among immunocompromised patients, and critical infection in immunocompetent patients is extremely rare. We report on a case of a brain abscess by Nocardia farcinica in an immunocompetent patient who received treatment with surgery and antibiotics. This is the second case of a brain abscess caused by N. farcinica in an immunocompetent patient in Korea.

Entities:  

Keywords:  Brain abscess; Immunocompetence; Nocardia infections

Year:  2014        PMID: 24693470      PMCID: PMC3970313          DOI: 10.3947/ic.2014.46.1.45

Source DB:  PubMed          Journal:  Infect Chemother        ISSN: 1598-8112


Introduction

Nocardia species are gram-positive, aerobic, branching filamentous bacteria belonging to Actinomycetales. Nocardia asteroides and Nocardia farcinica are the most frequent pathogen. Although infection commonly occurs through inhalation or direct cutaneous inoculation, Nocardia species can spread to the central nervous system hematogenously, usually in immunocompromised patients [1, 2]. Nocardia brain abscess in an immunocompetent patient has rarely been reported [3]. In Korea, only one case of Nocardia brain abscess in an immunocompetent host has been reported [4]. We report an immunocompetent patient who had a Nocardia brain abscess, which was treated by stereotactic aspiration of the abscess and systemic antibiotics. This is the second case of a brain abscess caused by N. farcinica in an immunocompetent patient in Korea.

Case Report

A 71-year-old male was admitted due to headache, dizziness, and nausea for three days. He was healthy, except that he had been diagnosed with hypertension two years before. His past medical history was unremarkable. His social history included intermittent alcohol consumption without smoking. The initial vital signs revealed blood pressure of 120/80 mmHg, heart rate of 76 beats per minute, respiration rate of 18 breaths per minute and body temperature of 36.9℃. He was alert upon admission. Physical examination revealed clear lung sound without rale or wheezing. The heart beat was regular without any murmur. There was no tenderness or rebound tenderness in the abdomen. Findings from other physical and neurological examinations were normal. There were no other symptoms such as fever, neck stiffness, photophobia, papilledema or other abnormalities. The initial peripheral blood count showed a white blood cell count of 11,200/mm3 (neutrophils 64.6%, lymphocytes 24.5%, monocytes 6.8%), hemoglobin level of 13.0 g/dL, platelet count of 211,000/mm3, erythrocyte sedimentation rate of 38 mm/hr, and C-reactive protein level of 1.11 mg/dL. Blood chemistry showed a total protein level of 7.6 g/dL, albumin level of 4.3 g/dL, total bilirubin level of 0.9 mg/dL, aspartate aminotransferase/alanine aminotransferase 27/16 IU/L, alkaline phosphatase 77 IU/L, BUN/Cr 9.2/0.8 mg/dL, Na/K 136/3.8 mEq/L, and Ca/P 9.0/4.7 mg/dL. Result of urinalysis was normal. Human immunodeficiency virus (HIV) antibody, hepatitis B surface antigen and hepatitis C antibody were all negative. Chest and abdomen radiographs were normal. Brain CT scan and magnetic resonance (MR) imaging showed multiple rim enhancing lesions with surrounding edema, which was presumed to be a brain abscess (Fig. 1).
Figure 1

Magnetic resonance imaging of brain. (A) T1-WI shows rim-enhancing lesion with associated edema in the right occipital lobe. (B) The dark signal on T2-WI and consistent thickness of the wall suggest a brain abscess.

After admission, the patient underwent a craniotomy with stereotactic aspiration of the abscess. During the operation, yellowish and turbid pus was aspirated and a cerebral abscess was diagnosed. Empirical parenteral antibiotics were started with ceftriaxone 2 g bid and metronidazole 500 mg tid. Gram stain of the pus showed beaded branching gram-positive bacilli. Urease test, esculin hydrolysis test, citrate test, and modified acid-fast stain using 1% acid alcohol were all positive and the bacteria grew at 42℃. Nocardia species were suggested by colonial morphology, Gram-stain, and modified acid fast bacillus (AFB) stain (Fig. 2). By manual, culture was identified as Nocardia species. For the accurate identification of Nocardia species, 16S ribosomal RNA (rRNA) gene-based polymerase chain reaction (PCR) and sequencing was carried out. Primers of 27F (5'-AGA GTT TGA TCM TGG CTC AG-3') and 1492R (5'-TAC GGY TAC CTT GTT ACG ACT T-3') were used for 16S rRNA gene amplification. Size of 1466 bp 16S rRNA gene amplification sequencing was carried out by Solgent (Solgent Co, Daejeon, Korea) company which uses Big Dye Terminator Cycle Sequencing Kit and ABI PRISM 3730 DNA analyzer (PE Applied Biosystem, Foster, CA, USA). It showed 100% concordance to N. farcinica (GenBank accession number: KC478309) by BLAST Similarity Searching in GenBank. The organism was susceptible to amikacin, imipenem, trimethoprim-sulfamethoxazole (TMP-SMX), ciprofloxacin, and resistant to erythromycin, kanamycin, ampicillin, gentamicin. After identifying the result of pus culture, the antibiotic regimen was changed to TMP-SMX (15 mg/kg of the TMP component per day) and imipenem 500 mg qid. Due to the persistence of the patient's symptoms, re-imaging was performed two weeks later. On day 24 of admission, the patient underwent a repeated craniotomy with stereotactic aspiration of the abscess because the abscess and surrounding edema have increased than before. Ciprofloxacin (400 mg every 12 h, intravenous) was added to the TMP-SMX treatment and changed from imipenem to meropenem. After performance of repeated surgery and administration of additional antibiotics, we observed improvement of the patient's symptoms. Contrast-enhanced brain CT scan performed three weeks after reoperation, showed substantial resolution of the brain lesion. Meropenem and ciprofloxacin were continued for six weeks. On hospital day 67, he was discharged to go home to complete four months of oral TMP-SMX therapy. On three-month follow-up brain CT after discharge, resolution of the brain abscess was confirmed.
Figure 2

(A) Yellowish, round colonies are found on a blood agar plate. (B) Gram-positive branched rods are observed (Gram stain, × 1000). (C) Modified acid-fast stain of a pus specimen (× 1000), shows branching, filamentous organism compatible with Nocardia species (white arrows).

Discussion

Nocardia species are branching filaments of gram-positive bacteria that are omnipresent in soil and water [5]. Sixteen species of Nocardia have been implicated in human infections [6]. Nocardia infections commonly arise in the immunocompromised states including organ transplants, leukemia, HIV, steroid abuse, and autoimmune disease [1]. Inhalation is the most common route of the infection. Isolated pulmonary infection is most common, followed by disseminated disease (13.5%). Isolated involvement of the skin (8.1%) and central nerve system (5.4%) has also been reported [7]. Nocardia species are a rare cause of cerebral abscess [3]. Nocardia brain abscess appears in a gradually progressive mass lesion, with specific neurologic findings. Seizures and focal neurological deficits are the most common clinical manifestations observed in patients with a Nocardia brain abscess [8]. Our patient was rarely represented with neurologic and toxic symptoms such as seizure, paralysis, dyspnea and fever. Most patients with a Nocardia brain abscess are immunocompromised or have received immunosuppressive therapy [3]. Nocardia brain abscess in an immunocompetent host overseas has rarely been reported, and only one case of Nocardia brain abscess, which accompanied semi-invasive pulmonary Aspergillosis, has been reported in Korea. In this case, the patient was not immunocompromised and had not received immunosuppressive therapy [4, 9, 10, 11]. The mortality rate for Nocardia brain abscess is higher than that for other bacterial cerebral abscesses. In general, the mortality rate for patients with Nocardia infection is three times higher than that for patients with other types of bacterial brain abscess. The higher mortality of Nocardia brain abscess is supposed to be associated with patient's immune state. According to one study, the mortality rate of immunocompromised patients was 55%, whereas the mortality rate of immunocompetent patients was 20% [8, 11]. It is difficult to diagnose the Nocardia infection using culture-based methods because Nocardia species grow slowly and are contaminated by faster growing competitors. The 16S rRNA gene sequencing method is a reliable and fast method for identification of Nocardia species [12]. In this case, colonial morphology, Gram stain, and modified AFB stain suggested Nocardia species. The species was identified as N. farcinica by 16S rRNA gene-based PCR and sequencing. For diagnosis of a Nocardia brain abscess, it is important to carry out the brain images and surgical interventions. Brain CT, demonstrating a hypodense, enhancing lesion with surrounding edema, is sensitive for discovery and localization of the lesion; however, it is not sufficient for diagnosis. On brain MRI, multiple concentric rims are seen in abscesses due to Nocardia. Because it occasionally occur that necrotic metastasis and brain tumors are wrongly recognized by imaging study, it is required to get a proper specimen through surgical intervention. Besides, in order to prevent treatment delay, early surgical intervention is also required [13]. Although the use of metronidazole and third generation cephalosporins has become the standard for empirical treatment of cerebral abscesses, initial antimicrobial therapy for cerebral nocardiosis was established for the use of TMP-SMX, amikacin, and imipenem because Nocardia species are occasionally resistant to these antibiotics [14, 15, 16]. In particular, TMP-SMX is the preferred initial treatment for a Nocardia brain abscess due to good tolerance and better cerebrospinal fluid penetration [17]. Due to its similar pharmacokinetic effect, good cerebrospinal fluid penetration, and its association with lower occurrence of seizure, meropenem is a theoretically attractive substitute for imipenem for patients with cerebral nocardiosis [18]. Because a nocardial abscess forms multilocular and thick walled lesions, surgical intervention is usually required in most cases of cerebral nocardiosis. Overall prognosis is favorable upon administration of appropriate surgical therapy and antibiotics [17, 19]. In this case, we performed reoperation and added ciprofloxacin to the TMP-SMX because the abscess and surrounding edema have increased than before and the pathogen was susceptible to ciprofloxacin. As a result, the patient has improved after repeated surgical intervention and antibiotics. In summary, Nocardia species are a rare cause of brain abscess in immunocompetent individuals. In Korea, this is the second report of an immunocompetent patient with a brain abscess caused by N. farcinica.
  19 in total

Review 1.  Brain abscess.

Authors:  D P Calfee; B Wispelwey
Journal:  Semin Neurol       Date:  2000       Impact factor: 3.420

2.  Primary brain abscess with Nocardia farcinica in an immunocompetent patient.

Authors:  Lisa Malincarne; Massimo Marroni; Claudio Farina; Guido Camanni; Marina Valente; Barbara Belfiori; Stefano Fiorucci; Piero Floridi; Angela Cardaccia; Giuliano Stagni
Journal:  Clin Neurol Neurosurg       Date:  2002-05       Impact factor: 1.876

Review 3.  Nocardiosis: review of clinical and laboratory experience.

Authors:  Michael A Saubolle; Den Sussland
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

4.  Nocardia brain abscess mimicking brain tumour in immunocompetent patients: report of two cases and review of the literature.

Authors:  A Menkü; A Kurtsoy; B Tucer; O Yildiz; H Akdemir
Journal:  Acta Neurochir (Wien)       Date:  2004-02-16       Impact factor: 2.216

5.  Disseminated Nocardia farcinica infection in a uraemia patient with idiopathic thrombocytopenia purpura receiving steroid therapy.

Authors:  Chih-Cheng Lai; Li-Na Lee; Lee-Jene Teng; Ming Shiou Wu; Jui-Chang Tsai; Po-Ren Hsueh
Journal:  J Med Microbiol       Date:  2005-11       Impact factor: 2.472

6.  Primary cerebellar nocardiosis and alveolar proteinosis.

Authors:  W G Oerlemans; E N Jansen; R L Prevo; M M Eijsvogel
Journal:  Acta Neurol Scand       Date:  1998-02       Impact factor: 3.209

7.  Nocardia asteroides cerebral abscess in immunocompetent hosts: report of three cases and review of surgical recommendations.

Authors:  I G Fleetwood; J M Embil; I B Ross
Journal:  Surg Neurol       Date:  2000-06

8.  Nocardiosis at the turn of the century.

Authors:  Maricela Valerio Minero; Mercedes Marín; Emilia Cercenado; Pablo Martín Rabadán; Emilio Bouza; Patricia Muñoz
Journal:  Medicine (Baltimore)       Date:  2009-07       Impact factor: 1.889

9.  Two cases of multidrug-resistant Nocardia farcinica infection in immunosuppressed patients and implications for empiric therapy.

Authors:  W Hitti; M Wolff
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-02       Impact factor: 3.267

Review 10.  Nocardia species: host-parasite relationships.

Authors:  B L Beaman; L Beaman
Journal:  Clin Microbiol Rev       Date:  1994-04       Impact factor: 26.132

View more
  14 in total

1.  Creation of an In-House Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Corynebacterineae Database Overcomes Difficulties in Identification of Nocardia farcinica Clinical Isolates.

Authors:  Mariola Paściak; Władysław Dacko; Joanna Sikora; Danuta Gurlaga; Krzysztof Pawlik; Grzegorz Miękisiak; Andrzej Gamian
Journal:  J Clin Microbiol       Date:  2015-06-03       Impact factor: 5.948

Review 2.  Nocardia cyriacigeorgica brain abscess in a patient on low dose steroids: a case report and review of the literature.

Authors:  Segev Gabay; Michal Yakubovsky; Ronen Ben-Ami; Rachel Grossman
Journal:  BMC Infect Dis       Date:  2022-07-21       Impact factor: 3.667

3.  Multiple brain abscesses due to Nocardia spp. in an immunocompetent patient

Authors:  Danilo E Trujillo; Stephanie Ortiz; Oscar Pérez; Camilo A Cortés; Jorge A Carrillo
Journal:  Biomedica       Date:  2020-03-01       Impact factor: 0.935

4.  Successful treatment of multifoci nocardial brain abscesses: a case report and literature review.

Authors:  Qingsheng Xu; Renya Zhan; Yiping Feng; Jiajia Chen
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

5.  Nocardia Farcinica Brain Abscess in an Immunocompetent Old Patient: A Case Report and Review of Literature.

Authors:  Dinesh Mohan Chaudhari; Pushpendra Nath Renjen; Raman Sardana; Hena Butta
Journal:  Ann Indian Acad Neurol       Date:  2017 Oct-Dec       Impact factor: 1.383

6.  Nocardia paucivorans cerebellar abscess: Surgical and pharmacotherapy.

Authors:  Yu Shimizu; Katsuhiro Tsuchiya; Hironori Fujisawa
Journal:  Surg Neurol Int       Date:  2019-02-22

7.  Immunocompetent patient with a brain abscess caused by Nocardia beijingensis in Latin America: A case report.

Authors:  David M Solano-Varela; Edgar M Barrios-Vidales; David F Plaza; William M Riveros; Julián Guzmán; Claudia E Chica; Manuel A Patarroyo
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

Review 8.  A clinical case report of brain abscess caused by Nocardia brasiliensis in a non-immunocompromised patient and a relevant literature review.

Authors:  Jian-Wei Zhu; Hui Zhou; Wei-Qiang Jia; Jian You; Ru-Xiang Xu
Journal:  BMC Infect Dis       Date:  2020-05-07       Impact factor: 3.090

9.  Molecular identification and antibiotic resistance pattern of actinomycetes isolates among immunocompromised patients in Iran, emerging of new infections.

Authors:  Hossein Ali Rahdar; Shahram Mahmoudi; Abbas Bahador; Fereshteh Ghiasvand; Fatemah Sadeghpour Heravi; Mohammad Mehdi Feizabadi
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

10.  Disseminated Nocardia farcinica in an immunocompetent patient.

Authors:  H Boamah; P Puranam; R M Sandre
Journal:  IDCases       Date:  2016-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.